Infection of quiescent cell cultures by adenoviruses and papovavirus results in the induction of cellular DNA synthesis. This induction is thought to reflect a requirement for cell cycle regulated expression or activation of either cellular or viral encoded functions critical for viral DNA replication. At least a partial mechanistic explanation for this may be found in the fact that these viruses can interfere with the ability of the tumor suppressor protein pRB to regulate the cellular transcription factor E2F. The role of pRB in regulating cell cycle events derives in part from the genetics of human retinoblastoma and also from studies which correlate release of E2F from complexes with pRB or a related protein p107 with activation of E2F-responsive genes, among which are several encoding cell cycle progression or DNA replication functions. The significance of this for virus replication is suggested by the failure of viruses to replicate if they are unable to affect pRB-E2F interactions. Representatives of the three groups of herpesviruses also induce DNA synthesis upon infection of quiescent or post-mitotic cells. This research proposal is designed to test that HSV affects cell cycle regulation by inducing an S phaselike state during the course of lytic replication. As a test of this hypothesis an using adenovirus promoter sequences as a probe, we have found that S phase-specific E2F DNA binding activities containing wither pRB or p107 as well a free E2F, are induced under the regulation of HSV gene products. We speculate that this induction process by HSV is a consequence of deregulating cell cycle check points and either leads to or reflects modifications of cellular functions required for virus replication on non-cycling cells. A more thorough understanding of the mechanism(s) of E2F induction by HSV should provide important insights into the mechanism of normal cell cycle regulation. The experiments in this proposal are designed to further explore the mechanism of induction, and the functional significance of E2F induction for the HSV replication cycle.
The specific aims i nclude the following: (i) determining whether HSV induced new expression of or modifies pre-existing components of E2F DNA- binding activities; (ii) determining how HSV infection alters the ability of E2F-pRB or p- 107 complexes to bind DNA and identifying additional E2F DNA binding activities utilizing promoter sequences of E2F-responsive promoters; and (iv) characterizing the induction of E2F complex formation in quiescent cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA019014-18
Application #
3729188
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
18
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
DeKroon, Robert M; Gunawardena, Harsha P; Edwards, Rachel et al. (2018) Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. MBio 9:
Nicholls, Thomas J; Nadalutti, Cristina A; Motori, Elisa et al. (2018) Topoisomerase 3? Is Required for Decatenation and Segregation of Human mtDNA. Mol Cell 69:9-23.e6
El-Mallawany, Nader Kim; Kamiyango, William; Villiera, Jimmy et al. (2018) Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol :1-7
Selitsky, Sara R; Marron, David; Mose, Lisle E et al. (2018) Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality. mSystems 3:
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Lyons, Danielle E; Yu, Kuan-Ping; Vander Heiden, Jason A et al. (2018) Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication. J Virol 92:
Bigi, Rachele; Landis, Justin T; An, Hyowon et al. (2018) Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 115:E11379-E11387
El-Mallawany, Nader Kim; Villiera, Jimmy; Kamiyango, William et al. (2018) Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease. Infect Agent Cancer 13:33
Kobayashi, E; Aga, M; Kondo, S et al. (2018) C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes. mSphere 3:
Hopcraft, Sharon E; Pattenden, Samantha G; James, Lindsey I et al. (2018) Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog 14:e1007267

Showing the most recent 10 out of 324 publications